title: Prolonged hypogammaglobulinemia following rituximab treatment for post transplant Epstein-Barr virus-associated lymphoproliferative disease.
authors.forename: S
authors.initials: S
authors.lastname: Imashuku
authors.forename: T
authors.initials: T
authors.lastname: Teramura
authors.forename: A
authors.initials: A
authors.lastname: Morimoto
authors.forename: M
authors.initials: M
authors.lastname: Naya
authors.forename: H
authors.initials: H
authors.lastname: Kuroda
mesh_terms: D000328:Adult; D000361:Agammaglobulinemia / Q000139:chemically induced*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D004854:Herpesvirus 4, Human; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000821:virology; D008297:Male; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab